Minimal hepatic encephalopathy impairs quality of life.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Clinical and Experimental Hepatology

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jceh.2014.11.006PMID 26041957PMCID PMC4442849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization

  2014cited by this paper
• Sleep‐wake abnormalities in patients with cirrhosis

  2014cited by this paper
• Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis

  2014cited by this paper
• Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients

  2013cited by this paper
• Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis

  2013cited by this paper
• Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking

  2013cited by this paper
• Cognitive dysfunction in cirrhosis is associated with falls: A prospective study

  2012cited by this paper
• Covert hepatic encephalopathy: not as minimal as you might think.

  2012cited by this paper
• Driving Simulation Can Improve Insight into Impaired Driving Skills in Cirrhosis

  2012cited by this paper
• Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver.

  2011cited by this paper
• The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers

  2011cited by this paper
• Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

  2011cited by this paper
• Hepatic encephalopathy: A central neuroinflammatory disorder?

  2011cited by this paper
• Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

  2011cited by this paper
• Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

  2011cited by this paper
• Minimal Hepatic Encephalopathy Is Associated With Falls

  2011cited by this paper
• Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver

  2010cited by this paper
• Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver

  2010cited by this paper
• Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.

  2010cited by this paper
• Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.

  2010cited by this paper
• Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

  2010cited by this paper
• Minimal hepatic encephalopathy

  2009cited by this paper
• Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy

  2009cited by this paper
• The Effect of Fatigue on Driving Skills in Patients With Hepatic Encephalopathy

  2009cited by this paper
• Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test

  2009cited by this paper
• Night‐time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis

  2009cited by this paper
• Patients with minimal hepatic encephalopathy have poor insight into their driving skills.

  2008cited by this paper
• Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study

  2008cited by this paper
• Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden

  2008cited by this paper
• Magnetic Resonance Imaging of Brain in Patients with Cirrhotic and Non-Cirrhotic Portal Hypertension

  2008cited by this paper
• Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy

  2008cited by this paper
• The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy.

  2008cited by this paper
• Minimal Hepatic Encephalopathy: A Vehicle for Accidents and Traffic Violations

  2007cited by this paper
• Value of the critical flicker frequency in patients with minimal hepatic encephalopathy

  2007cited by this paper
• Review article: the burden of hepatic encephalopathy

  2007cited by this paper
• Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

  2007cited by this paper
• Manganese induces cell swelling in cultured astrocytes.

  2007cited by this paper
• Minimal hepatic encephalopathy

  2007cited by this paper
• Hepatic encephalopathy as a predictor of survival in patients with end‐stage liver disease

  2007cited by this paper
• Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy

  2007cited by this paper
• Role of ammonia and inflammation in minimal hepatic encephalopathy

  2007cited by this paper
• Bone disorders in chronic liver disease

  2007cited by this paper
• Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy

  2006cited by this paper
• Neuropsychological abnormalities in cirrhosis include learning impairment.

  2006cited by this paper
• Early experience with HEADS: Hepatic encephalopathy assessment driving simulator

  2006cited by this paper
• The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

  2005cited by this paper
• American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension.

  2005cited by this paper
• Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts

  2005cited by this paper
• Psychological status and depression in patients with liver cirrhosis.

  2005cited by this paper
• Operative risk of total hip and knee arthroplasty in cirrhotic patients.

  2005cited by this paper
• Minimal hepatic encephalopathy impairs fitness to drive

  2004cited by this paper
• Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis

  2004cited by this paper
• Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

  2004cited by this paper
• Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability.

  2003cited by this paper
• Influence of Hepatic Encephalopathy on Health-Related Quality of Life in Patients with Cirrhosis

  2003cited by this paper
• Secretion of interleukin‐1β by astrocytes mediates endothelin‐1 and tumour necrosis factor‐α effects on human brain microvascular endothelial cell permeability

  2003cited by this paper
• [Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy].

  2003cited by this paper
• Memory function in early hepatic encephalopathy.

  2003cited by this paper
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Correlations Between Cerebral Glucose Metabolism and Neuropsychological Test Performance in Nonalcoholic Cirrhotics

  2002cited by this paper
• Factors associated with poor health-related quality of life of patients with cirrhosis.

  2001cited by this paper
• The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.

  2001cited by this paper
• Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

  2001cited by this paper
• Quality of Life in Cirrhotics with Minimal Hepatic Encephalopathy

  2001cited by this paper
• CHRONIC LIVER DISEASES: EPIDEMIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis

  2001cited by this paper
• Screening of subclinical hepatic encephalopathy.

  2000cited by this paper
• Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0

  2000cited by this paper
• Reliability and validity of the NIDDK‐QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease

  2000cited by this paper
• The prognostic significance of subclinical hepatic encephalopathy.

  2000cited by this paper
• Efficacy of Lactulose in Cirrhotic Patients with Subclinical Hepatic Encephalopathy

  2000cited by this paper
• The prognostic significance of subclinical hepatic encephalopathy

  2000cited by this paper
• Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

  1999cited by this paper
• Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

  1999cited by this paper
• High prevalence of sleep disturbance in cirrhosis

  1998cited by this paper
• Subclinical hepatic encephalopathy impairs daily functioning

  1998cited by this paper
• Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation.

  1996cited by this paper
• Subclinical Hepatic Encephalopathy

  1996cited by this paper
• Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells.

  1996cited by this paper
• The influence of cytokines on the integrity of the blood-brain barrier in vitro.

  1996cited by this paper
• Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability

  1995cited by this paper
• Predictors of Automobile Crashes and Moving Violations among Elderly Drivers

  1994cited by this paper
• Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance.

  1994cited by this paper
• Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy

  1991cited by this paper
• Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy.

  1990cited by this paper
• Osteoporosis and skeletal fractures in chronic liver disease.

  1990cited by this paper
• Latent portasystemic encephalopathy

  1981cited by this paper
• Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.

  1978cited by this paper
• Method for Measuring Cerebral Dysfunction in Patients with Liver Disease

  1970cited by this paper
• American Association for the Study of Liver Diseases: Symposium on Toxic Hepatic Injury

  1960cited by this paper

• Comparison of probiotics to lactulose for minimal hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.

  2026cites this paper
• Burden of Minimal Hepatic Encephalopathy in Literate Cirrhotics Aged 15-50 Years: Time to Switch to Digital Diagnostic Tools?

  2026cites this paper
• Hyperammonemia increases the release of pathological extracellular vesicles from monocytes by impairing lysosomal function and autophagy through the TNFα–cAMP–PKA–LC3 pathway

  2026influential citation
• Pediatric cirrhosis: special consideration for its diagnosis and management

  2025cites this paper
• Golexanolone Attenuates Neuroinflammation, Fatigue, and Cognitive and Motor Impairment in Diverse Neuroinflammatory Disorders

  2025cites this paper
• Translational artificial intelligence in gastrointestinal and hepatic disorders: Advancing intelligent clinical decision-making for diagnosis, treatment, and prognosis

  2025cites this paper
• Chinese Consensus on Clinical Diagnosis and Management of Covert Hepatic Encephalopathy

  2025cites this paper
• Machine learning techniques in hepatic encephalopathy: a scoping review

  2025cites this paper
• PerAF-based resting-state fMRI classifier for minimal hepatic encephalopathy

  2025cites this paper
• Extracellular Vesicles from Peripheral Blood Mononuclear Cells of Hyperammonemic Rats Induce Neuroinflammation in Hippocampus, Impairing Memory and Learning in Normal Rats

  2025cites this paper
• Preventing Readmissions for Hepatic Encephalopathy.

  2024cites this paper
• Comparison of 6 tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome: A prospective, observational study

  2024cites this paper
• Cilostazol Counteracts Mitochondrial Dysfunction in Hepatic Encephalopathy Rat Model: Insights into the role of cAMP/AMPK/SIRT1/ PINK-1/Parkin hub and p-CREB /BDNF/ TrkB neuroprotective trajectory.

  2024cites this paper
• Reversibility of structural and functional alterations of hepatic encephalopathy

  2024cites this paper
• Value of systemic inflammation markers for the detection of minimal and prediction of overt hepatic encephalopathy after TIPS insertion

  2024cites this paper
• Diacerein ameliorates thioacetamide-induced hepatic encephalopathy in rats via modulation of TLR4/AQP4/MMP-9 axis

  2024cites this paper
• Role of peripheral inflammation in minimal hepatic encephalopathy

  2024cites this paper
• The pharmacology of exercise: Strategies and challenges in the optimization of functional status in cirrhosis.

  2024cites this paper
• Functional connectivity disruption of insular subregions in the cirrhotic patients with minimal hepatic encephalopathy

  2024cites this paper
• Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials.

  2024cites this paper
• Metabolic disorder and functional disturbance in the central executive network in minimal hepatic encephalopathy.

  2024cites this paper
• The Glymphatic System May Play a Vital Role in the Pathogenesis of Hepatic Encephalopathy: A Narrative Review

  2023cites this paper
• The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas

  2023cites this paper
• Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: a study of the French Hospital-Discharge Database.

  2023cites this paper
• Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade’s Literature Focusing on Incidence, Risk Factors, and Prophylaxis

  2023cites this paper
• Determination of normative value of Psychometric hepatic encephalopathy score in Bangladeshi volunteers

  2023cites this paper
• Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests

  2023cites this paper
• A Nurse-Led Outpatient Clinic for Patients With Decompensated Liver Cirrhosis

  2023cites this paper
• Linagliptin attenuates thioacetamide-induced hepatic encephalopathy in rats: Modulation of C/EBP-β and CX3CL1/Fractalkine, neuro-inflammation, oxidative stress and behavioral defects.

  2022cites this paper
• Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities

  2022cites this paper
• The Assessment of Driving Fitness Using an On-Road Evaluation in Patients With Cirrhosis

  2022cites this paper
• Hepatic encephalopathy

  2022cites this paper
• Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

  2022influential citation
• A highly selective and sensitive spectrofluorimetric method for the assessment of 3-nitrotyrosine in serum using (Eu(TTA)3Phen) photo probe

  2022cites this paper
• Encephalopathy in Cirrhosis: Prevention and Management.

  2021cites this paper
• Identifying Mild Hepatic Encephalopathy Based on Multi-Layer Modular Algorithm and Machine Learning

  2021influential citation
• Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease

  2021cites this paper
• Factors Affecting Quality of Life in Liver Transplant Candidates: An Observational Study

  2021cites this paper
• Determination of Turkish Norms of Psychometric Tests For Diagnosing Minimal Hepatic Encephalopathy and Proposal of a Simpli�ed Paper Pencil Test Battery

  2021cites this paper
• Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery

  2021cites this paper
• Standardization of the psychometric hepatic encephalopathy score in a French population

  2021cites this paper
• Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial)

  2021cites this paper
• Animal Naming Test – a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy

  2020cites this paper
• The role of the hospitalist in the continuum of care for patients with hepatic encephalopathy: treatment of inpatient episodes and preventing outpatient recurrence and readmissions

  2020cites this paper
• Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study

  2020cites this paper
• Prediction of minimal encephalopathy in patients with HCV-related cirrhosis using albumin-bilirubin, platelets-albumin-bilirubin score, albumin-bilirubin-platelets grade and ammonia level

  2020cites this paper
• Validation of a Simple Quality‐of‐Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy

  2020cites this paper
• Clinical manifestations and management of fatty acid oxidation disorders

  2020cites this paper
• Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues

  2019cites this paper
• Hippocampal atrophy and functional connectivity disruption in cirrhotic patients with minimal hepatic encephalopathy

  2019cites this paper
• Oridonin prevents insulin resistance–mediated cognitive disorder through PTEN/Akt pathway and autophagy in minimal hepatic encephalopathy

  2019cites this paper
• Encefalopatía hepática: historia natural de la enfermedad, nueva clasificación e impacto en la calidad de vida

  2019cites this paper
• Hepatic Encephalopathy: Classification, Diagnosis, and Treatment

  2019cites this paper
• Chinese guidelines on management of hepatic encephalopathy in cirrhosis

  2019cites this paper
• Joint effects of advancing age and number of potentially inappropriate medication classes on risk of falls in Medicare enrollees

  2019cites this paper
• A novel neural computational model of generalized periodic discharges in acute hepatic encephalopathy

  2019cites this paper
• Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.

  2018cites this paper
• Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy

  2018cites this paper
• Systemic inflammation without gliosis mediates cognitive deficits through impaired BDNF expression in bile duct ligation model of hepatic encephalopathy.

  2018cites this paper
• The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies

  2018cites this paper
• 3-Nitro-Tyrosine as a Biomarker of Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis

  2018cites this paper
• Effects of rifaximin versus nonabsorbable disaccharides in hepatic encephalopathy

  2018cites this paper
• Integrating Palliative Principles into Cirrhosis Care: The Effect of Hepatic Encephalopathy

  2018cites this paper
• Recent Developments in Male Contraception

  2018cites this paper
• A Mean Field Model of Acute Hepatic Encephalopathy

  2018cites this paper
• Predicting Hepatic Encephalopathy‐Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis

  2018cites this paper
• Hepatic encephalopathy: causes and health-related burden.

  2018cites this paper
• Stroop Test Validation to Screen for Minimal Hepatic Encephalopathy in Pediatric Extrahepatic Portal Venous Obstruction

  2018cites this paper
• Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis.

  2017cites this paper
• Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study

  2017cites this paper
•  Minimal hepatic encephalopathy in cirrhosis- how long to treat?

  2017cites this paper
• Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea

  2017cites this paper
• Encéphalopathie hépatique chez les patiens atteints de cirrhose : le TIPS comme facteur de risque, apport de l'IRM multitmodale

  2017cites this paper
• Minimal hepatic encephalopathy in children, uncommon or unrecognised? Time to act.

  2017cites this paper
• Hepatic encephalopathy: a critical current review

  2017cites this paper
• Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy

  2017cites this paper
• Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients

  2016cites this paper
• Title Evaluation of cognitivity , proinflammatory cytokines , and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction Permalink

  2016cites this paper
• Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES)

  2016cites this paper
• Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction

  2016cites this paper
• Hepatic encephalopathy for the hospitalist.

  2016cites this paper
• From prolonging life to prolonging working life: Tackling unemployment among liver-transplant recipients.

  2016cites this paper
• Differences in cognitive function between patients with viral and alcoholic compensated liver cirrhosis

  2015cites this paper
• Liver Transplantation : Global view From prolonging life to prolonging working life : Tackling unemployment among liver-transplant recipients

  year unknowncites this paper